# MethMax Trial: MAXimising the METHotrexate Therapy Potential in Patients with Active Rheumatoid Arthritis

> **NCT06649136** · PHASE4 · RECRUITING · sponsor: **Medical University of Vienna** · enrollment: 182 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT06649136
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-12
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 182 (ESTIMATED)
- **Last updated:** 2024-10-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06649136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06649136, "MethMax Trial: MAXimising the METHotrexate Therapy Potential in Patients with Active Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06649136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*